Good Lab

Principal Investigator:

William Good

Contact Information:

Email: good@ski.org

2318 Fillmore Stret
San Francisco, CA 94115-1813

Our laboratory studies the conditions which cause monocular or bilateral blindness in infants and children.

infant receiving an eye exam

Fierson, W. ., Ophthalmology, A. A. of ., Pediatrics, A. A. of ., Ophthalmology and Strabismus, A. A. for P. . ., & Orthoptists, A. A. of C. . (2013). Screening examination of premature infants for retinopathy of prematurity. Pediatrics, 131(1), 189-95. 10.1542/peds.2012-2996 (Original work published 2013)

Good, W. V., Wong, R. J., Norcia, A. ., Hou, C. ., Cellucci, J. ., McGovern, M. ., … Bhutani, V. K. (2025). Effect of bilirubin on visuocortical development in preterm infants. Journal of Perinatology. 10.1038/s41372-025-02213-4 (Original work published 2025)

Wallace, D. K., Hercinovic, A. ., Freedman, S. ., Crouch, E. ., Bhatt, A. ., Hartnett, E. ., … Investigator Group, P. E. D. . (2023). Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 27(1), 10.e1-10.e8. 10.1016/j.jaapos.2022.11.020 (Original work published 2023)

Freedman, S. ., Hercinovic, A. ., Wallace, D. K., Kraker, R. ., Li, Z. ., Bhatt, A. ., … Good, W. V. (2022). Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology, 129(10), 1120-1128. 10.1016/j.ophtha.2022.05.019 (Original work published 2022)

Loveridge-Easther, C. ., & Good, W. V. (2022). Ocular neovascularization following hypoxic ischemic encephalopathy. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 26(4), 216-218. 10.1016/j.jaapos.2022.04.004 (Original work published 2022)

Fielder, A. ., Quinn, G. E., Chan, R. P., Holmström, G. E., Chiang, M. F., Classification Committee, I. 3 ., & Good, W. V. (2022). Retinopathy of prematurity classification updates: possible implications for treatment. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 26(3), 109-112. 10.1016/j.jaapos.2022.03.003 (Original work published 2022)

Good, W. V., Wong, R. J., Norcia, A. M., Stevenson, D. K., Slagel, T. ., Hou, C. ., & Bhutani, V. K. (2022). Bilirubin-induced neurotoxicity and visuocortical dysfunction. Journal of Perinatology, 43, 240-241. 10.1038/s41372-022-01417-2 (Original work published 2022)

Brodsky, M. C., & Good, W. V. (2021). Vision testing in cortical visual impairment: ocular motor confounders. Journal of the American Association for Pediatric Ophthalmology and Strabismus, 25(6), 322-323. 10.1016/j.jaapos.2021.06.007 (Original work published 2021)

Good, W. V. (2021). Ethics in the editorial process. Journal of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS), 25(5), 263-264. 10.1016/j.jaapos.2021.09.001 (Original work published 2021)

Chiang, M. F., Quinn, G. E., Fielder, A. R., Ostmo, S. R., Chan, R. P., Berrocal, A. ., … Zin, A. . (2021). International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology, 128(10), e51-e58. 10.1016/j.ophtha.2021.05.031 (Original work published 2021)

Gendron, R. L., Paradis, H. ., Ahmad, R. ., Kao, K. ., Boyce, D. ., Good, W. V., … Santander, J. . (2020). CD10+ Cells and IgM in Pathogen Response in Lumpfish (Cyclopterus lumpus) Eye Tissues. Frontiers in Immunology, 11, 576897. 10.3389/fimmu.2020.576897 (Original work published 2020)

Wallace, D. K., Kraker, R. ., Freedman, S. ., Crouch, E. ., Bhatt, A. ., Hartnett, E. ., … Investigator Group, P. E. D. . (2020). Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmology, 138(6), 698-701. 10.1001/jamaophthalmol.2020.0334 (Original work published 2020)